Nordson
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 76.08% -0.01pp
- Institutions
- 948 -3
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 28 sells
| Name | Role | Stake |
|---|---|---|
| Sundaram Nagarajan | Chief Executive Officer | 0.13% |
| James DeVries | Former Executive Vice President of Continuous Improvement | 0.09% |
| Victor Richey | Independent Chairperson | 0.04% |
| Frank Jaehnert | Independent Director | 0.04% |
| Ginger Jones | Independent Director | 0.01% |
| Srinivas Subramanian | -- | 0.01% |
| John DeFord | Independent Director | 0.01% |
| Jennifer A. Parmentier | Independent Director | 0.01% |
| Michael Merriman | Independent Director | 0.01% |
| Jennifer McDonough | General Counsel | 0.01% |
| Stephen Lovass | Former Executive Vice President of Medical and Fluid Solutions | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-31 | John DeFord | Independent Director | Other Acquisition | +660 | $322.67 |
| 2026-10-31 | Frank Jaehnert | Independent Director | Other Acquisition | +583 | $322.67 |
| 2026-10-31 | Victor Richey | Independent Chairperson | Other Acquisition | +583 | $322.67 |
| 2026-10-31 | Michael Merriman | Independent Director | Other Acquisition | +583 | $322.67 |
| 2026-10-31 | Christopher Mapes | Independent Director | Other Acquisition | +626 | $322.67 |
| 2026-10-31 | Ginger Jones | Independent Director | Other Acquisition | +583 | $322.67 |
| 2026-10-31 | Milton Morris | Independent Director | Other Acquisition | +583 | $322.67 |
| 2026-10-31 | Jennifer A. Parmentier | Independent Director | Other Acquisition | +583 | $322.67 |
| 2026-10-30 | Joseph Kelley | Executive VP of Industrial Precision Solutions Leader | Sale to Issuer | -1,481 | $322.67 |
| 2026-10-30 | Srinivas Subramanian | -- | Sale to Issuer | -593 | $322.67 |
| 2026-10-13 | Milton Morris | Independent Director | Open Market Disposition | -255 | $327.20 |
| 2026-09-14 | Joseph Rutledge | Vice President | Open Market Disposition | -684 | $309.38 |
| 2026-09-01 | Milton Morris | Independent Director | Open Market Disposition | -156 | $316.63 |
| 2026-08-31 | Justin Hall | Executive Vice President of Medical & Fluid Solutions | Sale to Issuer | -118 | $314.40 |
| 2026-08-26 | Jennifer McDonough | General Counsel | Open Market Disposition | -260 | $336.00 |
| 2026-08-25 | Daniel Hopgood | Chief Financial Officer | Derivative Exercise and Sale | -1,329 | $209.73–334.29 |
| 2026-07-30 | John DeFord | Independent Director | Other Acquisition | +84 | $297.78 |
| 2026-07-30 | Christopher Mapes | Independent Director | Other Acquisition | +42 | $297.78 |
| 2026-07-30 | Joseph Rutledge | Vice President | Sale to Issuer | -274 | $297.78 |
| 2026-06-03 | James DeVries | Former Executive Vice President of Continuous Improvement | Intent to Sell (Form 144) | -6,600 | $290.00 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Nordson discussion 0 comments